skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : TALLEY, DANIEL C.
Total Assignments: 2
Assignment: 1
Reel/Frame:053757/0380   Pages: 8
Recorded: 09/14/2020
Attorney Dkt #:4239-99971-04
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
03/22/2019
2
Exec Dt:
03/21/2019
3
Exec Dt:
03/25/2019
4
Exec Dt:
03/25/2019
5
Exec Dt:
03/25/2019
6
Exec Dt:
04/06/2019
7
Exec Dt:
03/25/2019
Assignee
1
OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH
6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660
BETHESDA, MARYLAND 20892-7660
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
16976012
Correspondence name and address
KLARQUIST SPARKMAN, LLP
121 SW SALMON ST., SUITE 1600
ONE WORLD TRADE CENTER
PORTLAND, OR 97204
Assignment: 2
Reel/Frame:063177/0361   Pages: 8
Recorded: 03/30/2023
Attorney Dkt #:4239-99971-05
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
Exec Dt:
03/22/2019
2
Exec Dt:
03/21/2019
3
Exec Dt:
03/25/2019
4
Exec Dt:
03/25/2019
5
Exec Dt:
03/25/2019
6
Exec Dt:
04/06/2019
7
Exec Dt:
03/25/2019
Assignee
1
OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH
6011 EXECUTIVE BOULEVARD, SUITE 325, MSC 7660
BETHESDA, MARYLAND 20892-7660
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
NONE
18128603
Correspondence name and address
KLARQUIST SPARKMAN, LLP
121 SW SALMON ST., SUITE 1600
ONE WORLD TRADE CENTER
PORTLAND, OR 97204

Search Results as of: 05/16/2024 07:35 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT